Live Breaking News & Updates on Navidea Biopharmaceuticals Inc|Page 7

Stay updated with breaking news from Navidea biopharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report issued on Saturday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.05 on Friday. The stock has a market capitalization of $5.01 million, a price-to-earnings ratio of -0.17 and a beta of […] ....

Therapeutic Development Programs , Navidea Biopharmaceuticals Company Profile , Allred Capital Management , Renaissance Technologies , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals , Free Report , Get Free Report , Capital Management , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals, Inc. Announces NYSE American's Decision to Suspend Trading In Its Common Stock

Navidea Biopharmaceuticals, Inc. Announces NYSE American's Decision to Suspend Trading In Its Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Theodore Gerbick , Navidea Manocept , Exchange Commission , Securities Exchange , Company Of The Panel , Navidea Biopharmaceuticals Inc , Listings Qualifications Panel , Chief Financial , Securities Act , Securities Exchange Act , Annual Report , Navidea Biopharmaceuticals ,

NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)

NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Exchange Commission , Navidea Biopharmaceuticals Inc , American Company Guide The , Company Of The Panel , Suspend Trading , Navidea Biopharmaceuticals , Listings Qualifications Panel , Company Guide ,

NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)

NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Exchange Commission , American Company Guide The , Company Of The Panel , Navidea Biopharmaceuticals Inc , Nyse American , Navidea Biopharmaceuticals , Listings Qualifications Panel , Company Guide ,

StockNews.com Begins Coverage on Navidea Biopharmaceuticals (NYSE:NAVB)

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Tuesday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of Navidea Biopharmaceuticals stock opened at $0.09 on Tuesday. The firm has a market capitalization of $9.32 million, a PE ratio […] ....

Allred Capital Management , Therapeutic Development Programs , Navidea Biopharmaceuticals Company Profile , Renaissance Technologies , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals , Free Report , Get Free Report , Capital Management , State Street Corp , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,